Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer.

Ulm, Michael A; Redfern, Tiffany M; Wilson, Ben R; Ponnusamy, Suriyan; Asemota, Sarah; Blackburn, Patrick W; Wang, Yinan; ElNaggar, Adam C; Narayanan, Ramesh

Ulm, Michael A; Redfern, Tiffany M; Wilson, Ben R; Ponnusamy, Suriyan; Asemota, Sarah; Blackburn, Patrick W; Wang, Yinan; ElNaggar, Adam C; Narayanan, Ramesh.

Afiliación

Ulm MA; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Redfern TM; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Wilson BR; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Ponnusamy S; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Asemota S; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Blackburn PW; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Wang Y; Department of Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
ElNaggar AC; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Narayanan R; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

J Pers Med ; 10(4)2020 Nov 26.

Article en En | MEDLINE | ID: mdl-33256002

Palabras clave

gene expression; integrin-linked kinase (ILK); microarray; ovarian cancer; sgRNA; xenograft

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pers Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google